Relay Therapeutics | search
Click here to view Relay Therapeutics news from 60+ newspapers.
Bookmark or Share- Dynamo Platform - Relay TherapeuticsMotion-Based Drug Design. Our Dynamo platform puts protein dynamics at the heart of our drug discovery process. We deploy our Dynamo platform in three key phases of Motion-Based Drug Design. Understand How To. Drug the Protein. Identify a Chemical. Starting Point. Optimize Until Development. Candidate Selected.
- Relay TherapeuticsView Open Positions. May 2, 2024. April 25, 2024. Relay Therapeutics® puts protein motion at the heart of drug discovery to dramatically expand therapeutic possibilities.
- Investors & Media | Relay TherapeuticsCompany Overview. We are a clinical-stage precision medicines company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients.
- Relay Therapeutics Announces Initial Clinical Data Demonstrating that ...Relay Therapeutics Announces Initial Clinical Data Demonstrating that RLY-2608 Selectively Targets Multiple PI3Kα Mutations. April 18, 2023. Download PDF. Multiple doses achieved sustained target exposure of ~80%+ mutant PI3Kα inhibition. No Grade 3 hyperglycemia, rash or diarrhea observed at target exposures.
- Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data ...Relay Therapeutics’ initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. For more information, please visit www.relaytx.com or follow us on Twitter .
More
